Publicacións (136) Publicacións de JOSÉ MARÍA LADERO QUESADA

2021

  1. Genetic variants of alcohol metabolizing enzymes and alcohol-related liver cirrhosis risk

    Journal of Personalized Medicine, Vol. 11, Núm. 5

2016

  1. GC gene polymorphism and unbound serum retinol-binding protein 4 are related to the risk of insulin resistance in patients with chronic hepatitis c: A prospective cross-sectional study

    Medicine (United States), Vol. 95, Núm. 10

  2. The relation of fibrosis stage with nutritional deficiencies and bioelectrical impedance analysis of body composition in patients with chronic hepatitis C

    Annals of Hepatology, Vol. 15, Núm. 4, pp. 492-500

2015

  1. Matrix Metalloproteinase 10 Contributes To Hepatocarcinogenesis in a Novel Crosstalk With the Stromal Derived Factor 1/C-X-C Chemokine Receptor 4 Axis

    Hepatology, Vol. 62, Núm. 1, pp. 166-178

  2. Transarterial chemoembolisation in intermediate-Stage hepatocellular carcinoma. Survey on clinical practice in hospitals in the Madrid Region

    Annals of Hepatology, Vol. 14, Núm. 2, pp. 207-217

  3. Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

    Journal of Viral Hepatitis, Vol. 22, Núm. 5, pp. 469-480

2013

  1. Influence of Vitamin D-Related Gene Polymorphisms (CYP27B and VDR) on the Response to Interferon/Ribavirin Therapy in Chronic Hepatitis C

    PLoS ONE, Vol. 8, Núm. 9

  2. Sorafenib for non-selected patient population with advanced hepatocellular carcinoma: Efficacy and safety data according to liver function

    Clinical and Translational Oncology, Vol. 15, Núm. 2, pp. 146-153

  3. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C

    Annals of Hepatology, Vol. 12, Núm. 2, pp. 199-204

2012

  1. Analysis of the functional polymorphism in the cytochrome P450 CYP2C8 gene rs11572080 with regard to colorectal cancer risk

    Frontiers in Genetics, Vol. 3, Núm. DEC

  2. Hyperuricemia and metabolic syndrome in children with overweight and obesity

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 59, Núm. 9, pp. 533-538

  3. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma

    Oncology, Vol. 82, Núm. 1, pp. 35-40

  4. Predicting response to therapy in chronic hepatitis C: An approach combining interleukin-28B gene polymorphisms and clinical data

    Journal of Gastroenterology and Hepatology (Australia), Vol. 27, Núm. 2, pp. 279-285

  5. Relation of IL28b gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease

    PLoS ONE, Vol. 7, Núm. 5

  6. Serum cystatin C: A non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?

    Annals of Hepatology, Vol. 11, Núm. 5, pp. 648-651

2011

  1. Noninvasive evaluation of liver fibrosis in patients with chronic hepatitis C

    Hepatitis Monthly

2010

  1. CYP2W1 variant alleles in Caucasians and association of the CYP2W1 G541A (Ala181Thr) polymorphism with increased colorectal cancer risk

    Pharmacogenomics, Vol. 11, Núm. 7, pp. 919-925

  2. Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: A comparative analysis of nine scoring methods

    Scandinavian Journal of Gastroenterology, Vol. 45, Núm. 1, pp. 51-59

  3. Tratamiento de la hepatitis crónica C: situación actual y perspectivas

    Anales de la Real Academia Nacional de Medicina, Núm. 3, pp. 413-433

2009

  1. Analysis of a non-synonymous single nucleotide polymorphism of the human diamine oxidase gene (ref. SNP ID: Rs1049793) in patients with Crohn's disease

    Scandinavian Journal of Gastroenterology, Vol. 44, Núm. 10, pp. 1207-1212